The Turkish Version of the Self-perceived Barriers for Physical Activity Questionnaire

October 5, 2024 updated by: Tansu Birinci, Istanbul University - Cerrahpasa (IUC)

Cross-cultural Adaptation, Reliability, and Validity of the Turkish Version of Self-perceived Barriers for Physical Activity Questionnaire

The Self-perceived Barriers for Physical Activity Questionnaire (SBPAQ) is originally developed in Spanish to evaluate self-perceived barriers for physical activity participation in healthy individuals. The purpose of this study is to translate and cross-culturally adapt the SBPAQ into Turkish and investigate its psychometric properties.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Completed

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Detailed Description

The Self-perceived Barriers for Physical Activity Questionnaire (SBPAQ) is originally developed in Spanish to evaluate self-perceived barriers for physical activity participation in healthy individuals. The purpose of this study is to translate and cross-culturally adapt the SBPAQ into Turkish and investigate its psychometric properties. Approximately two hundred healthy individuals aged between 18-65 years will be included. For cross-cultural adaptation, two bi-lingual translators will use the back-translation procedure. After the questionnaire will be translated into Turkish, the reliability, validity, and internal consistency of the Turkish version of SBPAQ (SBPAQ-T) will be tested. The questionnaire will be applied twice within 7 days to evaluate the test-retest reliability and to calculate the "Intraclass Correlation Coefficient" (ICC). Pearson correlation coefficient will be used to analyze construct and convergent/divergent validity. The construct validity of SBPAQ-T will be analyzed based on its correlation with the Physical Activity Barriers Questionnaire, International Physical Activity Questionnaire-Short Form, and Short Form-12. The Cronbach's Alpha will be calculated to determine internal consistency. The level of significance is considered as 0.05. The floor and ceiling effects will be detected.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Observational

Enrollment (Actual)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
153

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey
    • Bakırkoy
      • Istanbul, Bakırkoy, Turkey, 34147
        • Istanbul University-Cerrahpaşa

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

All participants are healthy individuals aged between 18-65 years.

Description

Inclusion Criteria:

  • Being aged between 18-65 years
  • Having the ability to read and write Turkish
  • Having good cooperation to complete the assessment
  • Being a volunteer to participate in the study

Exclusion Criteria:

  • Having any musculoskeletal disease, cardiorespiratory system problem, or movement limitation in any joint that prevents participation in physical activity
  • Having undergone surgery affecting the musculoskeletal system in the last 3 months
  • Being pregnant
  • Having a neurological or cognitive impairment
  • Having any movement disorder
  • Having the vision and/or hearing problems

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Case-Only
  • Time Perspectives: Cross-Sectional

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
The Self-perceived Barriers for Physical Activity Questionnaire (SBPAQ)
Time Frame: Baseline (First assessment)
The Self-perceived Barriers for Physical Activity Questionnaire (SBPAQ) is composed of 17 items and 4 subscales: 1) Body image &psychosocial anxiety (5-item); 2) Fatigue & laziness (3-item); 3) Obligations & lack of time (3-item); and 4) Environment & facilities (4-item). The SBPAQ is a comprehensive and valid scoring system to evaluate perceived barriers to physical activity participation in healthy individuals.
Baseline (First assessment)

Secondary Outcome Measures

Secondary Outcome Measures

In a clinical study's protocol, a planned outcome measure that is not as important as the primary outcome measure for evaluating the effect of an intervention but is still of interest. Most clinical studies have more than one secondary outcome measure.
Outcome Measure
Measure Description
Time Frame
The Self-perceived Barriers for Physical Activity Questionnaire (SBPAQ)
Time Frame: Within a 7-day period after the first assessment (Second assessment)
The Self-perceived Barriers for Physical Activity Questionnaire (SBPAQ) is composed of 17 items and 4 subscales: 1) Body image &psychosocial anxiety (5-item); 2) Fatigue & laziness (3-item); 3) Obligations & lack of time (3-item); and 4) Environment & facilities (4-item). The SBPAQ is a comprehensive and valid scoring system to evaluate perceived barriers to physical activity participation in healthy individuals.
Within a 7-day period after the first assessment (Second assessment)
International Physical Activity Questionnaire - Short Form (IPAQ-SF)
Time Frame: Baseline (First assessment)
International Physical Activity Questionnaire - Short Form (IPAQ-SF) is composed of 7 items to assess the types of intensity of physical activity and sitting time that people do as part of their daily lives are considered to estimate total physical activity in metabolic equivalent (MET)-min/week and time spent sitting in youth 15 years of age and older.
Baseline (First assessment)
Physical Activity Barriers Questionnaire (PABQ)
Time Frame: Baseline (First assessment)
Physical Activity Barriers Questionnaire (PABQ) is composed of 24 items and 3 subscales: 1) Personal Barriers (14-item); 2) Social Barriers (3-item); 3) Environmental Barriers (6-item). The PABQ is a comprehensive and valid scoring system to evaluate perceived barriers to physical activity participation in healthy individuals.
Baseline (First assessment)
Short Form-12 (SF-12)
Time Frame: Baseline (First assessment)
Short Form-12 (SF-12), which is developed based on Short Form-36, consists of 12 items: 7 items dealing with the physical components scores (PCS-12) and 5 items related to the mental components scores (MCS-12) of SF-12. Range of both scores is 0 to 100, where the higher scores indicate better health related quality of life.
Baseline (First assessment)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Istanbul University - Cerrahpasa (IUC)

Investigators

Investigators

A researcher involved in a clinical study. Related terms include site principal investigator, site sub-investigator, study chair, study director, and study principal investigator.
  • Principal Investigator: Tansu Birinci, PT, PhD, Istanbul Medeniyet Universitesi

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
November 25, 2022

Primary Completion (Actual)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
December 30, 2022

Study Completion (Actual)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
January 21, 2023

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
August 20, 2022

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
August 20, 2022

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
August 23, 2022

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
October 8, 2024

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
October 5, 2024

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
February 1, 2023

More Information

Terms related to this study

Keywords

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • 210822

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings